Chronic, Low Dose Erythropoetin Beta in Ischemic Cardiomyopathy
NCT00568542
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class
Conditions
Ischemic Cardiomyopathy
Interventions
DRUG:
erythropoetin beta
DRUG:
placebo
Sponsor
Charite University, Berlin, Germany